Roche and Exiqon to ally on PCR product marketing

Roche is to ally with fellow life science company Exiqon on a joint marketing initiative for their product offerings in the polymerase chain reaction (PCR) segment.

The deal will see the two companies ally on marketing the RealTime ready assay range from Roche Applied Science and Exiqon’s miRCURY LNA Universal RT microRNA PCR system.

Both products are designed for use in the analysis of biological samples for a variety of scientific and healthcare purposes, including research into the process involved in the development of diseases.

A key aspect of this joint marketing initiative, for which financial details were not disclosed, is the fact that both product ranges’ abilities complement those of the other.

The collaboration will encompass a number of online advertising and information campaigns via webinars and seminars.

Earlier this month, Roche announced that it has also entered into a new alliance with Qiagen that will lead to the development of new PCR diagnostic assays for cancer detection.